Emmaus Life Sciences, Inc.
EMMA
$0.01
$0.000.99%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.02% | -82.91% | 51.29% | -33.30% | -195.68% |
| Total Depreciation and Amortization | 0.00% | 275.00% | -20.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | 34.51% | 10.94% | 29.29% | 30.26% | 10.14% |
| Total Other Non-Cash Items | -19.63% | 225.78% | -495.06% | 122.82% | 63.31% |
| Change in Net Operating Assets | 117.14% | 220.40% | -153.99% | -13.86% | 1,394.51% |
| Cash from Operations | 440.10% | 114.06% | -1,142.29% | -18.66% | 131.76% |
| Capital Expenditure | -- | 100.00% | -- | -- | -700.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -- | -- | -- |
| Cash from Investing | -- | -100.00% | -- | -- | -300.00% |
| Total Debt Issued | 152.72% | -34.84% | 68.49% | 32.53% | 13.75% |
| Total Debt Repaid | -59.42% | -33.07% | -12.70% | -40.36% | 10.74% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 63.87% | -452.82% | 182.32% | -76.92% | 55.48% |
| Foreign Exchange rate Adjustments | -1,400.00% | -80.00% | -50.00% | 183.33% | -163.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 409.80% | -32.14% | -700.00% | -141.79% | 149.63% |